Coya Therapeutics, Inc. (COYA) vs Immunic, Inc. (IMUX)
A side-by-side comparison of Coya Therapeutics, Inc. and Immunic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$5.01HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
IMUX
Immunic, Inc.
$7.89HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — COYA vs IMUX
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)IMUX -37.9% (-11.2%/yr)COYA compounded faster over this window
COYA IMUX
COYA vs IMUX: by the numbers
- •COYA is the larger company ($117M vs $107M market cap).
- •Both run net losses; IMUX's is the smaller (0.00% vs -270.22% net margin).
Metrics side by side
Valuation
| Metric | COYA | IMUX |
|---|---|---|
| P/S ratio | 14.65 | N/A |
| P/B ratio | 0.00 | 0.84 |
Profitability
| Metric | COYA | IMUX |
|---|---|---|
| Gross margin | 99.91% | 0.00% |
| Operating margin | -255.05% | 0.00% |
| Net margin | -270.22% | 0.00% |
| ROE | -0.05% | -87.45% |
| ROIC | -0.05% | -92.16% |
Growth (annualized)
| Metric | COYA | IMUX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -35.70% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.